PubMed Health⌕ Search

Biomedical subjects

H P HIGGINS

Publications and source records attributed to H P HIGGINS.

9 recordsLinked to original sources
PubMed1964

PROGNOSTIC VALUE OF HIGH 10-MINUTE I-131 UPTAKE IN NON-TOXIC GOITRES.

Forty-two patients with non-toxic goitre and with a high 10-minute uptake of I(131) were treated with 100 mug. of l-triiodothyronine per day for periods up to 36 months. All of the goitres were reduced in size and 10 showed marked regression within one week. Hashimoto's disease was considered an unlikely cause of these goitres because only four of 20 tested had positive antithyroglobulin tests, and these were of low titre (up to 1:81). Chromatographic studies suggested a defect in thyroxine metabolism in many of these patients. It is concluded that a high 10-minute uptake test is useful in predicting a response to therapy and in selecting patients likely to have a detectable defect in thyroxine metabolism.

Adolescent↗
PubMed1964

THE EFFECT OF POVIDONE-IODINE (BETADINE) ON SERUM PROTEIN-BOUND IODINE, WHEN USED AS A SURGICAL PREPARATION ON INTACT SKIN.

A study was undertaken to determine whether the use of povidone-iodine (Betadine) as a skin disinfectant prior to surgery would affect the protein-bound iodine (PBI) and so invalidate this parameter of thyroid function.Ninety-seven consecutive patients were chosen who had no thyroid disease and who had not recently been exposed to iodine in any form. Their serum PBI levels were determined before and after a wide variety of surgical operations. Povidone-iodine was used as a skin disinfectant in the operating room in all cases. Care was taken to avoid contact of the povidone-iodine with the mucous membranes.No significant change in the protein-bound iodine could be detected and it was concluded that there could be no objection to the use of povidone-iodine on the ground of its possible effect on the protein-bound iodine.

Blood Proteins↗
PubMed1962

Metabolic studies on patients with resistant heart failure treated by spironolactone.

Metabolic balance studies were carried out on five patients with resistant heart failure treated with spironolactone and other diuretics. Spironolactone alone had little effect. When it was used in a daily dose of 400-600 mg. in combination with hydrochlorothiazide 100 mg. daily, the results were excellent in two patients. One of these was still free of failure after 12 months on combined therapy. In the other patient the serum potassium became elevated after a good diuresis, though on subsequent intermittent therapy with the drug the patient remained well for 12 months. In two other patients administration of spironolactone had to be discontinued because of elevation of the serum potassium before a good diuresis could take place. The fifth patient died.Spironolactone can be a useful adjunct to the therapy of resistant heart failure, but there appears to be a real danger of causing the serum potassium to rise to toxic levels in patients so treated.

Diuresis↗